Business Development

Backed by over two decades of pharmaceutical development expertise and proprietary technologies, we provide a decisive edge — accelerating time to market while creating optimal delivery systems for your therapeutic candidates.

Opt for our non-IP-based, fee-for-service model to retain full control while leveraging our expert formulation support.

We conduct proof-of-concept studies to demonstrate the potential of our technologies for your drug. Reach out to evaluate how our solutions can benefit your compound.

If you have a promising drug but no optimized delivery system, we invite you to partner with us. Benefits include:

Accelerated time-to-market with an optimized delivery system
Generation of new intellectual property to strengthen both parties’ portfolios
Differentiation from competitors through superior patient-friendly formats

Whether you need targeted analytical experiments or full outsourcing, your project can be launched within one month. Steps include:

1. Initial Contact
Reach out to our CSO, Prof. Dr. Andreas Bernkop-Schnürch:

✆ +43 650 753 6270 | ✉ a.bernkop[at]thiomatrix.com

2. Confidentiality Agreement
Sign a CDA to enable open dialogue.

3. Project Checklist
Complete our project checklist outlining your goals and data.

4. Free Project Proposal
Based on discussions and your data, we will provide a no-obligation proposal including objectives, timelines, and costs.

5. Study Protocol
Upon agreement, a GLP-compliant protocol will be prepared.

6. Project Execution
Studies are conducted as agreed, with regular updates.

7. Reporting & Presentations
Interim and final reports are delivered, along with presentations to review findings.